§ 360dd. Open protocols for investigations of drugs for rare diseases or conditions
121 words·~1 min read·
/usc/title-21/section-360ddA research copy — for the controlling text, always check the official state or federal source. Not legal advice.
If a drug is designated under section 360bb of this title as a drug for a rare disease or condition and if notice of a claimed exemption under section 355(i) of this title or regulations issued thereunder is filed for such drug, the Secretary shall encourage the sponsor of such drug to design protocols for clinical investigations of the drug which may be conducted under the exemption to permit the addition to the investigations of persons with the disease or condition who need the drug to treat the disease or condition and who cannot be satisfactorily treated by available alternative drugs.
(June 25, 1938, ch. 675, § 528, as added Pub. L. 97–414, § 2(a), Jan. 4, 1983, 96 Stat. 2051.)
Connections9 cite this · traces to 2
Cited by 9 sections
public-private-law
statutes-at-large
statute-compilations
Traces to 2 documents
3 references not yet in our index
- June 25, 1938, ch. 675, § 528
- Pub. L. 97–414, § 2(a)
- 96 Stat. 2051
Citation graph
cites case law
§ 360dd
Open protocols for investigations of drugs for rare diseases or conditions
Fed. Reg.×3
Bills×2
Stat.×2
Pub. L.×1
Stat. Comp.×1
ActJune 25, 1938, ch. 675, § 528
Pub. L.Pub. L. 97–414, § 2(a)
Stat.96 Stat. 2051
Cites 5Cited by 9 across 5 sources